Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chorum Pharmaceuticals was a small private pharmaceutical company based in California that appears to have operated primarily as a holding and research-collaboration vehicle rather than as a fully built-out clinical-stage biotech. Publicly available references tie the company to Dean "Rick" Artis, who served as President and CSO for more than seven years and described the business as pursuing research collaborations across diverse therapeutic areas. There is no clear evidence of an active clinical pipeline, marketed products, or current operating presence. Corporate registry sources indicate the entity is no longer active, and available information suggests it ceased operations rather than being acquired. Overall, Chorum Pharmaceuticals appears to have been an early-stage pharma-oriented company with limited public disclosure and no clearly documented late-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chorum Pharmaceuticals.